Horizon 3 Biotech Pty Ltd ACN 640 449 887 AFSL Authorised Representative No 001282862. Horizon 3 Biotech is the fund manager of the Horizon3 Biotech Fund (Fund). Melbourne Securities Corporation Limited ACN 160 326 545 AFSL 428289 (Trustee) is the trustee of the Fund. The Fund is only available to investors who are Wholesale Clients, and are not Retail Clients, all within the meaning of the Corporations Act 2001. Horizon 3 Biotech Pty Ltd is an authorised representative of BK Consulting (Aust) Pty Ltd ACN 134 397 08, AFSL 334906. Horizon 3 Biotech is authorised to provide general financial product advice and to deal in interests in Australian managed investment schemes. This website contains general information only and does not take into account any person’s objectives, financial situation or needs and accordingly does not constitute personal advice for the purposes of section 766B(3) of the Corporations Act 2001.

The general information on this website does not constitute an offer to invest in the Fund and should not be used as the basis for making an investment in the Fund. Before making an investment in the Fund, you should consider important information about risks, costs and fees in the relevant disclosure document available by contacting info@horizon3biotech.com. The Information Memorandum for the relevant Fund is available by contacting Michael Sullivan via info@horizon3biotech.com. Any investment is subject to risk, including possible loss of income or capital invested. None of Horizon 3 Biotech Pty Ltd, the Trustee, Melbourne Securities Corporation Limited or any of their officers, advisers, agents or associates guarantees in any way the performance of the Fund. Past performance is not an indicator of future returns. The content of this website is current at the time of publication and may be amended or revoked by Horizon 3 Biotech Pty Ltd at any time.